Aberrant nerve excitability: An in-depth study of HCN channel activity in neurological disorders (epilepsy and chronic neuropathic pain).

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chronic neuropathic pain and epilepsy carry a high burden of disease, and have a major impact on health resources. Abnormal nerve excitability is implicated in both conditions. This study evaluates the use of a non-invasive test applied to peripheral nerve in the measurement of nerve excitability in neuropathic pain and epilepsy. The aim is to establish a sensitive biomarker of disease in assessment and diagnosis of patients, and to help direct therapy and measure response to treatment.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2019

Funding Scheme: Early Career Fellowships

Funding Amount: $205,315.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Neurosciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | epilepsy | genetic influences | ion channels | nerve excitability | neuropathic pain